Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
J Nucl Med
    July 2021
  1. WOFF E, Salvatore L, Marmorino F, Genovesi D, et al
    Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
    J Nucl Med. 2021 Jul 29. pii: jnumed.120.245357. doi: 10.2967/jnumed.120.245357.
    >> Share

    April 2021
  2. COHEN AS, Grudzinski J, Smith GT, Peterson TE, et al
    First-in-human PET imaging and estimated radiation dosimetry of L-[5-(11)C]-glutamine in patients with metastatic colorectal cancer.
    J Nucl Med. 2021 Apr 30. pii: jnumed.120.261594. doi: 10.2967/jnumed.120.261594.
    >> Share

    March 2021
  3. ALSULTAN AA, van Roekel C, Barentsz MW, Smits MLJ, et al
    Dose-response and dose-toxicity relationships for yttrium-90 glass radioembolization in patients with colorectal cancer liver metastases.
    J Nucl Med. 2021 Mar 19. pii: jnumed.120.255745. doi: 10.2967/jnumed.120.255745.
    >> Share

    October 2020
  4. DE JONGH SJ, Vrouwe JPM, Voskuil FJ, Schmidt I, et al
    The Optimal Imaging Window for Dysplastic Colorectal Polyp Detection Using c-Met-Targeted Fluorescence Molecular Endoscopy.
    J Nucl Med. 2020;61:1435-1441.
    >> Share

    June 2020
  5. VAN ROEKEL C, Bastiaannet R, Smits MLJ, Bruijnen RC, et al
    Dose-effect relationships of holmium-166 radioembolization in colorectal cancer.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.243832. doi: 10.2967/jnumed.120.243832.
    >> Share

    May 2020
  6. ABBOTT EM, Falzone N, Lee BQ, Kartsonaki C, et al
    The Impact of Radiobiologically-Informed Dose Prescription on the Clinical Benefit of Yttrium-90 SIRT in Colorectal Cancer Patients.
    J Nucl Med. 2020 May 1. pii: jnumed.119.233650. doi: 10.2967/jnumed.119.233650.
    >> Share

  7. CUDA TJ, Riddell AD, Liu C, Whitehall VL, et al
    PET imaging quantifying (68)Ga-PSMA-11 uptake in metastatic colorectal cancer.
    J Nucl Med. 2020 May 1. pii: jnumed.119.233312. doi: 10.2967/jnumed.119.233312.
    >> Share

  8. DE JONGH SJ, Tjalma JJJ, Koller M, Linssen MD, et al
    Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer.
    J Nucl Med. 2020;61:655-661.
    >> Share

    March 2019
  9. AVALLONE A, Aloj L, Pecori B, Caraco C, et al
    (18)F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer.
    J Nucl Med. 2019 Mar 15. pii: jnumed.118.222604. doi: 10.2967/jnumed.118.222604.
    >> Share

  10. WOFF E, Kehagias P, Vandeputte C, Ameye L, et al
    Combining (18)F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.222919. doi: 10.2967/jnumed.118.222919.
    >> Share

    February 2019
  11. FRAUM TJ, Fowler KJ, Crandall JP, Laforest RA, et al
    Measurement Repeatability of (18)F-FDG-PET/CT versus (18)F-FDG-PET/MRI in Solid Tumors of the Pelvis.
    J Nucl Med. 2019 Feb 7. pii: jnumed.118.218735. doi: 10.2967/jnumed.118.218735.
    >> Share

    June 2018
  12. WOFF E, Hendlisz A, Ameye L, Garcia C, et al
    Metabolic Active Tumor Volume and Total Lesion Glycolysis by (18)F-FDG PET/CT Validated as Prognostic Imaging Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.210161. doi: 10.2967/jnumed.118.210161.
    >> Share

    February 2018
  13. SCHELHAAS S, Wachsmuth L, Hermann S, Rieder N, et al
    Thymidine Metabolism as Confounding Factor of 3'-Deoxy-3'-[(18)F]Fluorothymidine Uptake after Therapy in a Colorectal Cancer Model.
    J Nucl Med. 2018 Feb 23. pii: jnumed.117.206250. doi: 10.2967/jnumed.117.206250.
    >> Share

    October 2017
  14. GRKOVSKI M, Emmas SA, Carlin SD
    18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
    J Nucl Med. 2017;58:1567-1573.
    >> Share

    September 2017
  15. BOAS FE, Bodei L, Sofocleous CT
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
    J Nucl Med. 2017;58.
    >> Share

    March 2017
  16. HOUARD C, Pinaquy JB, Henriques DE Figueiredo B, Mesguich C, et al
    Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in post-treatment evaluation of anal carcinoma.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.185280. doi: 10.2967/jnumed.116.185280.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016